RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in RVL Pharmaceuticals plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q2 2021
- Shares held
- 4.03M
- −795.3K (−16.5%) vs. Q2 2021
- Total value
- $11.9M
- −$2.67M (−18.4%) vs. Q2 2021
- New holders
- 1
- 12 more added
- Sold out
- 12
- 12 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 140 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 43 | $127 | 0.00% | −4,304−99.0% | Reduced |
| The PNC Financial Services Group, Inc. | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 1,299 | $4.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 1,440 | $4.00K | 0.00% | +10+0.7% | Added |
| Advisor Group Holdings, Inc. | 1,687 | $5.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,931 | $5.00K | 0.00% | +170+9.7% | Added |
| Barclays PLC | 2,425 | $7.00K | 0.00% | −2,684−52.5% | Reduced |
| Citigroup Inc | 3,526 | $10.0K | 0.00% | −1,607−31.3% | Reduced |
| JPMorgan Chase & Co | 4,253 | $13.0K | 0.00% | −33,353−88.7% | Reduced |
| UBS Group AG | 4,988 | $15.0K | 0.00% | +3,289+193.6% | Added |
| Bank of America Corp | 6,214 | $18.0K | 0.00% | +3,463+125.9% | Added |
| Tower Research Capital LLC (TRC) | 7,848 | $23.0K | 0.00% | +1,086+16.1% | Added |
| Walleye Trading LLC | 10,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,078 | $36.0K | 0.00% | 00.0% | Unchanged |
| Nations Financial Group Inc, | 12,500 | $37.0K | 0.01% | +12,500 | New |
| ProShare Advisors LLC | 13,434 | $40.0K | 0.00% | +2,165+19.2% | Added |
| Insight Advisors, LLC | 24,800 | $45.0K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 17,010 | $50.0K | 0.00% | +10,000+142.7% | Added |
| HRT Financial LP | 22,866 | $67.0K | 0.00% | −13,195−36.6% | Reduced |
| Zebra Capital Management LLC | 24,384 | $72.0K | 0.09% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 25,920 | $76.0K | 0.00% | −8,938−25.6% | Reduced |
| Northern Trust Corp | 26,157 | $77.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,120 | $80.0K | 0.00% | −29,193−51.8% | Reduced |
| State Street Corp | 34,184 | $101.0K | 0.00% | +3,900+12.9% | Added |
| Ergoteles LLC | 41,349 | $122.0K | 0.00% | −15,851−27.7% | Reduced |
| Deutsche Bank AG | 71,103 | $210.0K | 0.00% | +18,149+34.3% | Added |
| Dimensional Fund Advisors LP | 74,778 | $220.0K | 0.00% | +17,553+30.7% | Added |
| Millennium Management LLC | 127,563 | $376.0K | 0.00% | −32,577−20.3% | Reduced |
| Geode Capital Management, LLC | 146,432 | $431.0K | 0.00% | −9,286−6.0% | Reduced |
| BlackRock Inc. | 170,502 | $503.0K | 0.00% | +3,252+1.9% | Added |
| Vanguard Group Inc | 210,434 | $621.0K | 0.00% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 563,553 | $1.66M | 0.07% | +263,245+87.7% | Added |
| Renaissance Technologies LLC | 917,049 | $2.71M | 0.00% | −56,053−5.8% | Reduced |
| Morgan Stanley | 1,422,775 | $4.20M | 0.00% | −245,876−14.7% | Reduced |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −339,129−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −80,827−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −61,991−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −57,958−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −53,724−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −35,028−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −27,966−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,077−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −1,020−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −730−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −111−100.0% | Sold out |